193 related articles for article (PubMed ID: 28035400)
1. AMPK activators suppress breast cancer cell growth by inhibiting DVL3-facilitated Wnt/β-catenin signaling pathway activity.
Zou YF; Xie CW; Yang SX; Xiong JP
Mol Med Rep; 2017 Feb; 15(2):899-907. PubMed ID: 28035400
[TBL] [Abstract][Full Text] [Related]
2. AMPK activators suppress cervical cancer cell growth through inhibition of DVL3 mediated Wnt/β-catenin signaling activity.
Kwan HT; Chan DW; Cai PC; Mak CS; Yung MM; Leung TH; Wong OG; Cheung AN; Ngan HY
PLoS One; 2013; 8(1):e53597. PubMed ID: 23301094
[TBL] [Abstract][Full Text] [Related]
3. Metformin and AICAR regulate NANOG expression via the JNK pathway in HepG2 cells independently of AMPK.
Shen C; Ka SO; Kim SJ; Kim JH; Park BH; Park JH
Tumour Biol; 2016 Aug; 37(8):11199-208. PubMed ID: 26939902
[TBL] [Abstract][Full Text] [Related]
4. AMPK inhibits MTDH expression via GSK3β and SIRT1 activation: potential role in triple negative breast cancer cell proliferation.
Gollavilli PN; Kanugula AK; Koyyada R; Karnewar S; Neeli PK; Kotamraju S
FEBS J; 2015 Oct; 282(20):3971-85. PubMed ID: 26236947
[TBL] [Abstract][Full Text] [Related]
5. 5'-AMP-activated protein kinase (AMPK) regulates progesterone receptor transcriptional activity in breast cancer cells.
Wu L; Huang XJ; Yang CH; Deng SS; Qian M; Zang Y; Li J
Biochem Biophys Res Commun; 2011 Dec; 416(1-2):172-7. PubMed ID: 22093824
[TBL] [Abstract][Full Text] [Related]
6. AMP-activated kinase (AMPK) regulates activity of HER2 and EGFR in breast cancer.
Jhaveri TZ; Woo J; Shang X; Park BH; Gabrielson E
Oncotarget; 2015 Jun; 6(17):14754-65. PubMed ID: 26143491
[TBL] [Abstract][Full Text] [Related]
7. Anticancer properties of pomolic acid-induced AMP-activated protein kinase activation in MCF7 human breast cancer cells.
Youn SH; Lee JS; Lee MS; Cha EY; Thuong PT; Kim JR; Chang ES
Biol Pharm Bull; 2012; 35(1):105-10. PubMed ID: 22223345
[TBL] [Abstract][Full Text] [Related]
8. AICAR and Metformin Exert AMPK-dependent Effects on INS-1E Pancreatic β-cell Apoptosis via Differential Downstream Mechanisms.
Dai YL; Huang SL; Leng Y
Int J Biol Sci; 2015; 11(11):1272-80. PubMed ID: 26435693
[TBL] [Abstract][Full Text] [Related]
9. Ursolic acid-induced AMP-activated protein kinase (AMPK) activation contributes to growth inhibition and apoptosis in human bladder cancer T24 cells.
Zheng QY; Jin FS; Yao C; Zhang T; Zhang GH; Ai X
Biochem Biophys Res Commun; 2012 Mar; 419(4):741-7. PubMed ID: 22387548
[TBL] [Abstract][Full Text] [Related]
10. Role of AMP-activated protein kinase activators in antiproliferative multi-drug pituitary tumour therapies: effects of combined treatments with compounds affecting the mTOR-p70S6 kinase axis in cultured pituitary tumour cells.
Tulipano G; Faggi L; Cacciamali A; Spinello M; Cocchi D; Giustina A
J Neuroendocrinol; 2015 Jan; 27(1):20-32. PubMed ID: 25323047
[TBL] [Abstract][Full Text] [Related]
11. Antiplatelet effect of AMP-activated protein kinase activator and its potentiation by the phosphodiesterase inhibitor dipyridamole.
Liu Y; Oh SJ; Chang KH; Kim YG; Lee MY
Biochem Pharmacol; 2013 Oct; 86(7):914-25. PubMed ID: 23876340
[TBL] [Abstract][Full Text] [Related]
12. Regulation of metformin response by breast cancer associated gene 2.
Buac D; Kona FR; Seth AK; Dou QP
Neoplasia; 2013 Dec; 15(12):1379-90. PubMed ID: 24403860
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of cervical cancer cell growth through activation of upstream kinases of AMP-activated protein kinase.
Yu SY; Chan DW; Liu VW; Ngan HY
Tumour Biol; 2009; 30(2):80-5. PubMed ID: 19407487
[TBL] [Abstract][Full Text] [Related]
14. Metformin inhibits growth of human non-small cell lung cancer cells via liver kinase B-1-independent activation of adenosine monophosphate-activated protein kinase.
Guo Q; Liu Z; Jiang L; Liu M; Ma J; Yang C; Han L; Nan K; Liang X
Mol Med Rep; 2016 Mar; 13(3):2590-6. PubMed ID: 26847819
[TBL] [Abstract][Full Text] [Related]
15. Activation of the AMP-activated protein kinase reduces inflammatory nociception.
Russe OQ; Möser CV; Kynast KL; King TS; Stephan H; Geisslinger G; Niederberger E
J Pain; 2013 Nov; 14(11):1330-40. PubMed ID: 23916727
[TBL] [Abstract][Full Text] [Related]
16. miR-204-5p promotes the adipogenic differentiation of human adipose-derived mesenchymal stem cells by modulating DVL3 expression and suppressing Wnt/β-catenin signaling.
He H; Chen K; Wang F; Zhao L; Wan X; Wang L; Mo Z
Int J Mol Med; 2015 Jun; 35(6):1587-95. PubMed ID: 25847080
[TBL] [Abstract][Full Text] [Related]
17. Use of metformin alone is not associated with survival outcomes of colorectal cancer cell but AMPK activator AICAR sensitizes anticancer effect of 5-fluorouracil through AMPK activation.
Sui X; Xu Y; Yang J; Fang Y; Lou H; Han W; Zhang M; Chen W; Wang K; Li D; Jin W; Lou F; Zheng Y; Hu H; Gong L; Zhou X; Pan Q; Pan H; Wang X; He C
PLoS One; 2014; 9(5):e97781. PubMed ID: 24849329
[TBL] [Abstract][Full Text] [Related]
18. AICAR, an activator of AMPK, inhibits adipogenesis via the WNT/β-catenin pathway in 3T3-L1 adipocytes.
Lee H; Kang R; Bae S; Yoon Y
Int J Mol Med; 2011 Jul; 28(1):65-71. PubMed ID: 21491080
[TBL] [Abstract][Full Text] [Related]
19. Effects of metformin on cell growth and AMPK activity in pituitary adenoma cell cultures, focusing on the interaction with adenylyl cyclase activating signals.
Faggi L; Giustina A; Tulipano G
Mol Cell Endocrinol; 2018 Jul; 470():60-74. PubMed ID: 28962892
[TBL] [Abstract][Full Text] [Related]
20. Combined treatment with Metformin and 2-deoxy glucose induces detachment of viable MDA-MB-231 breast cancer cells in vitro.
Bizjak M; Malavašič P; Dolinar K; Pohar J; Pirkmajer S; Pavlin M
Sci Rep; 2017 May; 7(1):1761. PubMed ID: 28496098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
